CLDF Title
Home | Contact Us | Bookmark
About CLDF Centers of Educational Expertise  
Live CME Meetings Webcasts Slide Library Abstract Library Conference Highlights
Reuters Health Information (2010-02-08): For obese, consider using a longer vaccine needle


For obese, consider using a longer vaccine needle

Last Updated: 2010-02-08 19:57:22 -0400 (Reuters Health)

NEW YORK (Reuters Health) - Ever-expanding waistlines may have outgrown the doctor's needle, according to a February 8 online first publication in Pediatrics, in what could be another casualty of the obesity epidemic.

In a new study, the researchers report that using a standard 1-inch needle to immunize obese adolescents against hepatitis B virus produced a much weaker effect than using a longer needle.

"As obesity rises in the U.S., we need to be aware that the standard of care may have to change to protect obese youth," study co-author Dr. Amy Middleman of Baylor College of Medicine in Houston told Reuters Health.

Over three years her team vaccinated 22 young women and two young men in the shoulder, randomly assigning them to be injected with either a 1-inch or a 1.5-inch needle.

The two groups turned out to have different antibody titers depending on the needle used. In those injected with the short one, the number was almost halved, although everyone in the study had a high enough titer to be considered protected against hepatitis B.

"It gives us more evidence of the importance of choosing the right needle length," said Dr. Middleman, "because we just don't know what the impact could be in other vaccines."

The results are no surprise, said Dr. Gregory Poland, who studies vaccines at the Mayo Clinic in Rochester, Minnesota. For years, doctors have known that vaccines tend not to work as well in heavy people. Whether the obese have weaker immune systems, or fat keeps shorter needles from reaching muscles where the vaccines can affect immune cells, was unclear.

The introduction of the hepatitis B vaccine in the 1980s offered some clues. Soon after doctors began using the vaccine, they realized that it was failing to protect some female nurses.

At the time, the shot was given in the buttock, Dr. Poland told Reuters Health, and was thwarted by the padding there.

Instead of entering the muscle as it was supposed to, the vaccine apparently was broken down in the fat tissue, where it had little chance to affect immune cells. So doctors began giving the shot in the less-padded shoulder.

With the obesity epidemic now adding extra insulation to the shoulder, "our needles are going to have to be longer," Dr. Poland said.

And those long needles aren't as unpleasant as they sound. In fact, Dr. Poland said, "they turn out to be less painful and have fewer side effects."

The Centers for Disease Control and Prevention recommends longer needles in obese patients, but it is unclear how many doctors follow these guidelines, or even know about them.

Women are more affected by needle length than men, because their fat distribution is different. But even obese women shouldn't be overly concerned until more research has been done, Dr. Middleman cautioned.

"Should you go back and get all your immunizations repeated?" she said, "No, I don't think so."

Pediatrics 2010.

Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Sponsors & Supporters
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
Centers of
Educational Expertise
Substance Use Disorder
CLDF Follow Us
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2018 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.